Scientists at Michigan Medicine have made a significant breakthrough in treating nonalcoholic fatty liver disease (NAFLD), a ...

Non-alcoholic fatty liver disease (NAFLD) is regarded as a manifestation of metabolic syndrome in the liver. This investigation was initiated to determine whether NAFLD has a relationship to ...

A recent study from Université Laval suggests that camu-camu, an exotic fruit native to the Amazon, may help address ...

HBV感染是我国慢性肝病最常见的病因，也是世界范围内的重大公共卫生问题。截至2022年，全球慢性HBV感染者约2.57亿，我国约有7 974万例HBV感染者。随着生活方式的改变，非酒精性脂肪性肝病（NAFLD）的患病率在全球内呈上升趋势。根据Riazi等报道的全球最新的流行病学数据，NAFLD的全球总体患病率估计为32.4%。Zhou等对8项NAFLD流行病学研究进行的荟萃分析显示，我国NAFLD ...

慢性乙型肝炎（CHB）是由乙型肝炎病毒（HBV）引起的一种严重肝脏疾病，是全球范围内影响人类健康的主要公共卫生问题。随着生活方式的变迁，代谢病的患病率不断上升，其中代谢相关脂肪性肝病（MASLD，原名非酒精性脂肪性肝病NAFLD）逐渐成为全球健康的重要挑战。研究者越来越关注这两种疾病的共存现象及其对病程的影响。

肝脏巨噬细胞在调节肝细胞代谢和维持肝脏免疫耐受方面发挥核心作用。正常生理条件下，肝脏巨噬细胞倾向于 M2 表型，可通过分泌白细胞介素（IL）-4 和 IL-13 抑制炎症。然而，在 NAFLD 进展时，肝星状细胞激活、血液中脂多糖水平升高以及 FFA 激活炎症小体等变化，会刺激炎症发生，增加分泌促炎细胞因子的 M1 巨噬细胞比例。

近日，Journal of Diabetes and its Complications期刊发表的一项研究显示：在2型糖尿病（T2DM）合并非酒精性脂肪肝病（NAFLD）患者中，司美格鲁肽联合二甲双 ...

In the medical field, terminology not only guides clinical understanding and patient communication but also impacts research, ...

Nat Clin Pract Gastroenterol Hepatol. 2009;6(1):18-19. Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in the Western world. NAFLD is associated with chronic ...

A study revealed highly specific gut microbiome signatures for NAFLD, using machine learning to differentiate the disease ...

Actor Amitabh Bachchan advocates for a national campaign against non-alcoholic fatty liver disease, highlighting its severity and increasing prevalenc ...